Genomic-scale analysis of psoriatic skin reveals differentially expressed insulin-like growth factor-binding

M Hochberg1, S Zeligson, N Amariglio

  • 1Department of Dermatology, Hadassah Hebrew University Medical School, IL-91010 Jerusalem, Israel. malka@hadassah.org.il

Abstract

Insights

Phototherapy effectively treats psoriasis by altering gene expression. This study found insulin-like growth factor-binding protein-7 (IGFBP7) is underexpressed in psoriasis but increases with UVB treatment.

Area of Science:

  • Dermatology and Molecular Biology
  • Photomedicine

Background:

  • Phototherapy is a recognized treatment for psoriasis.
  • The precise molecular mechanisms driving phototherapy's effectiveness remain unclear.

Purpose of the Study:

  • To investigate molecular changes in psoriatic epidermis post-phototherapy.
  • To elucidate the mechanisms behind phototherapy's efficacy in psoriasis treatment.

Main Methods:

  • Oligonucleotide microarrays were used to analyze epidermal gene expression profiles before and after phototherapy (Dead Sea heliotherapy and narrowband ultraviolet B).
  • Insulin-like growth factor-binding protein-7 (IGFBP7) expression was further quantified using real-time PCR and immunohistochemistry.

Main Results:

  • Phototherapy modulated 315 genes, with distinct changes observed for Dead Sea treatment and narrowband UVB.
  • Key modulated genes included S100 calcium-binding proteins, dendritic cell markers, and TNF-alpha target genes.
  • Insulin-like growth factor-binding protein-7 (IGFBP7) mRNA and protein were significantly upregulated by phototherapy, despite being underexpressed in psoriatic skin.

Conclusions:

  • Insulin-like growth factor-binding protein-7 (IGFBP7) is downregulated in psoriatic epidermis.
  • UVB phototherapy can induce the expression of IGFBP7 in psoriatic skin, suggesting a role in treatment efficacy.

Related Concept Videos